MARISSA GIUNTA: Open Payments
NPI 1649091653 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 26 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $132 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 6 | $162 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $78 |
| TOLMAR, INC. | 3 | $70 |
| Endo USA, Inc. | 4 | $67 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| 180 Medical, Inc. | 2 | $53 |
| Dendreon Pharmaceuticals LLC | 1 | $41 |
| Olympus America Inc. | 1 | $35 |
| Boston Scientific Corporation | 1 | $29 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $20 |
Products named: PYLARIFY, ELIGARD, XIAFLEX, GEMTESA, GENTLECATH GLIDE, PROVENGE, SOLTIVE, AMS 700.
Industry payments across IL — which companies pay providers there.
